一个由36名老世界皮肤莱什曼病患者治疗的病例系列
Zahra Saffarian1, Zahra Vasfi Marandi2, Safoura Shakoei1
1Drs. Saffarian and Shakoei are with the Dermatology Department of Imam Khomeini Hospital Complex and Razi Dermatology Hospital at Tehran University of Medical Science in Tehran, Iran.
The Journal of clinical and aesthetic dermatology
|July 15, 2024
概括
肌肉内注射的梅格胺抗酸在伊朗的皮肤莱什曼病治疗中显示出更高的疗效. 减少注射间隔的内溶性梅格胺抗酸改善了清除率和减少了复发率.
科学领域:
- 皮肤病学 皮肤病学
- 传染性疾病 传染性疾病
- 寄生虫学的寄生虫学
背景情况:
- 皮肤莱什曼病 (CL) 是伊朗的一种严重的寄生虫疾病.
- 调查治疗结果和并发症对于管理CL至关重要.
- 这项研究侧重于2018年至2019年期间在伊朗被诊断患有CL的患者.
相关概念视频
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


